<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal CancerChristos S. Karapetis, John Zalcberg, Derek J. Jonker et al.|New England Journal of Medicine|2008Cited by 3.6k
Expression of Epiregulin and Amphiregulin and <i>K-ras</i> Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With CetuximabShirin Khambata‐Ford, David J. Mauro|Journal of Clinical Oncology|2007Cited by 1.1k